DFD-01, a Novel Medium Potency Betamethasone Dipropionate 0.05% Emollient Spray, Demonstrates Similar Efficacy to Augmented Betamethasone Dipropionate 0.05% Lotion for the Treatment of Moderate Plaque Psoriasis

Fowler Joseph E. Jr.; Hebert Adelaide A.; Sugarman Jeffrey

首页> 外文期刊>Journal of drugs in dermatology: JDD >DFD-01, a Novel Medium Potency Betamethasone Dipropionate 0.05% Emollient Spray, Demonstrates Similar Efficacy to Augmented Betamethasone Dipropionate 0.05% Lotion for the Treatment of Moderate Plaque Psoriasis

【24h】

DFD-01, a Novel Medium Potency Betamethasone Dipropionate 0.05% Emollient Spray, Demonstrates Similar Efficacy to Augmented Betamethasone Dipropionate 0.05% Lotion for the Treatment of Moderate Plaque Psoriasis

机译：DFD-01，一种新型中等效力的倍他米松双丙酸酯0.05％润肤剂喷雾，与增强型倍他米松双丙酸酯0.05％乳液治疗中度斑块状牛皮癣的功效相似

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: A novel 0.05% betamethasone dipropionate emollient spray (DFD-01) was formulated to optimize penetration of steroid to the epidermal layers affected by psoriasis.

机译：背景：配制了新型的0.05％倍他米松二丙酸酯润肤喷雾（DFD-01），以优化类固醇对受牛皮癣影响的表皮层的渗透性。

著录项

来源
《Journal of drugs in dermatology: JDD》 |2016年第2期|共9页
作者
Fowler Joseph E. Jr.; Hebert Adelaide A.; Sugarman Jeffrey;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
专利

1. DFD-01, a Novel Medium Potency Betamethasone Dipropionate 0.05% Emollient Spray, Demonstrates Similar Efficacy to Augmented Betamethasone Dipropionate 0.05% Lotion for the Treatment of Moderate Plaque Psoriasis [J] . Fowler Joseph E. Jr., Hebert Adelaide A., Sugarman Jeffrey Journal of drugs in dermatology: JDD . 2016,第2期

机译：DFD-01，一种新型中等效力的倍他米松双丙酸酯0.05％润肤剂喷雾，与增强型倍他米松双丙酸酯0.05％乳液治疗中度斑块状牛皮癣的功效相似
2. Improvement in Extensive Moderate Plaque Psoriasis With a Novel Emollient Spray Formulation of Betamethasone Dipropionate 0.05% [J] . Linda Stein Gold, J. Mark Jackson, Melissa L.F. Knuckles, Journal of drugs in dermatology: JDD . 2016,第3期

机译：用新型润肤剂喷涂配方的广泛适度的斑块牛皮癣改善β1005％
3. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis. [J] . Menter A, Abramovits W, Colon LE, Journal of drugs in dermatology: JDD . 2009,第1期

机译：将0.05％丙酸氯倍他索喷雾剂与卡泊三烯0.005％倍他米松双丙酸酯0.064％软膏剂进行比较，以治疗中度至重度斑块状牛皮癣。
4. Treatment Satisfaction Product Perception and Quality of Life in Plaque Psoriasis Patients Using Betamethasone Dipropionate Spray 0.05 [O] . Joseph F. Fowler, James Q. Del Rosso, Refika I. Pakunlu, 2017

机译：使用倍他米松二丙酸酯喷雾剂治疗斑块状银屑病患者的治疗满意度产品认知度和生活质量0.05％
5. Phase 3 Trial Demonstrates that MC2-01 Cream has Improved Treatment Efficacy Compared to Calcipotriene Plus Betamethasone Dipropionate Topical Suspension in Patients with Mild to Moderate Psoriasis Vulgaris [O] . Johan Selmer, Birgitte Vestbjerg, Morten Præstegaard, 2020

机译：第3阶段试验表明，与钙二烯加上的苯二乙烯加倍甲基替代酮双丙酸酯局部局部悬浮液相比，MC2-01乳膏具有改善的治疗效果，以温和至中等牛皮癣患者

DFD-01, a Novel Medium Potency Betamethasone Dipropionate 0.05% Emollient Spray, Demonstrates Similar Efficacy to Augmented Betamethasone Dipropionate 0.05% Lotion for the Treatment of Moderate Plaque Psoriasis

摘要

著录项

相似文献

相关主题

期刊订阅